An Advertising Agency Perspective of Food and Drug Administration Pharmaceutical Regulation

Abstract

This paper discusses the current state of the pharmaceutical industry, particularly the large drop in advertising pages in medical journals, the declining reputation of the industry in Washington, the drop in industry supported continuing medical education (CME), and the Food and Drug Administration (FDA) draft policy. Also discussed is the industry's support for the Washington Legal Foundation's Citizen Petition before the FDA arguing for greater recognition of the pharmaceutical advertising industry's First Amendment rights.